Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gilkerson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biopharmaceutics & Drug Disposition|March 25, 1998
Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimensS Eppler, T Senn, E Gilkerson, et al.
The Journal of Pediatrics|May 1, 1976
Granulopoiesis in childhood aplastic anemiaA H Ragab, E Gilkerson, W M Crist, et al.
Transfusion|May 1, 1979
Serum opsonins and chemotactins in neutropenic oncology patientsD A Stempel, O B Eden, E Gilkerson, et al.
The Journal of Bone and Joint Surgery. American Volume|September 1, 1987
The effect of antibiotics on the destruction of cartilage in experimental infectious arthritisR L Smith, D J Schurman, G Kajiyama, et al.
Journal of Immunological Methods|November 13, 1996
An evaluation of the accuracy of four ELISA methods for measuring natural and recombinant human interferon-gB D Paasch, B R Reed, R Keck, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Validation of a rat pheochromocytoma (PC12)-based cell survival assay for determining biological potency of recombinant human nerve growth factorH Gazzano-Santoro, A Chen, B Casto, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biopharmaceutics & Drug Disposition|March 25, 1998
Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimensS Eppler, T Senn, E Gilkerson, et al.
The Journal of Pediatrics|May 1, 1976
Granulopoiesis in childhood aplastic anemiaA H Ragab, E Gilkerson, W M Crist, et al.
Transfusion|May 1, 1979
Serum opsonins and chemotactins in neutropenic oncology patientsD A Stempel, O B Eden, E Gilkerson, et al.
The Journal of Bone and Joint Surgery. American Volume|September 1, 1987
The effect of antibiotics on the destruction of cartilage in experimental infectious arthritisR L Smith, D J Schurman, G Kajiyama, et al.
Journal of Immunological Methods|November 13, 1996
An evaluation of the accuracy of four ELISA methods for measuring natural and recombinant human interferon-gB D Paasch, B R Reed, R Keck, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Validation of a rat pheochromocytoma (PC12)-based cell survival assay for determining biological potency of recombinant human nerve growth factorH Gazzano-Santoro, A Chen, B Casto, et al.
Pageof 1